Podcasts about healthcare finance

Send us a textHealth coaching is often overlooked in healthcare, but could it be the key to improving behavior change, supporting chronic care, and filling gaps left by clinical shortages? In this episode of CareTalk: Healthcare. Unfiltered., Eugene Borukhovich, COO & Co-Founder of YourCoach, joins John Driscoll to discuss why coaching is gaining traction, how YourCoach is helping scale it, and why embracing health coaches could be critical to building a stronger, more sustainable healthcare system.

Send us a textMedicaid spending is almost certain to get cut significantly under the emerging Congressional reconciliation bill. But what is Medicaid anyway and what will happen if spending drops?

Send us a textChronic pain affects more Americans than cancer, heart disease, and diabetes combined, yet it remains one of the most misunderstood and poorly managed health conditions.In this episode of the CareTalk Podcast, John Driscoll sits down with Jennie Shulkin, Founder of Override Health, to discuss how her personal experience with chronic pain led to building a virtual, team-based care model that can revolutionize pain management as we know it.

In this episode, Alan Condon, Editor-in-Chief at Becker's Healthcare, discusses the latest financial performance of major health systems, the impact of rising costs, and the ongoing challenges with payer reimbursements. Listen in for key insights on the evolving healthcare landscape.

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com The key to improving the patient financial experience lies in personalized, transparent, and empathetic billing practices, moving beyond traditional, impersonal revenue cycle management.  In this episode, Dugan Winkie, Head of Commercial Strategy for Cedar, discusses how his company is revolutionizing the patient financial experience. His company uses a B2B2C model, partnering with providers to interact directly with patients on all billing matters, offering solutions ranging from simple bill payments to complex affordability options. Dugan emphasizes how they differentiate themselves by creating a personalized experience that guides patients through the complexities of healthcare finance. He also explains that Cedar prioritizes data integration to accurately answer complex billing questions and offer a truly integrated patient experience.  Tune in and learn about the future of patient financial engagement and how to create a transparent, personalized, and empathetic experience with the patient billing process! Resources:  Connect and follow Dugan Winkie on LinkedIn. Learn more about Cedar on their LinkedIn and website. Read Cedar's annual report here. Fast Track Your Business Growth: Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

In this episode, Laura Dyrda, Vice President and Editor-in-Chief at Becker's Healthcare, discusses financial stability, workforce shortages, and the role of technology in shaping the future of healthcare, offering valuable insights from industry experts and recent reports.

In this episode, Editor-in-Chief Alan Condon joins Laura Dyrda to discuss major healthcare finance developments, including Kaiser Permanente's recent acquisitions, the rapid expansion of urgent care centers, and the shift towards value-based care.

For the first time in history, Texas is home to three female presidents leading Healthcare Financial Management Association (HFMA) chapters, alongside the organization's first female CEO, Ann Jordan. This unprecedented moment is more than symbolic; it highlights a shift toward inclusivity, collaboration, and innovation in healthcare financial management. With Texas chapters spanning diverse regions and communities, these leaders are driving initiatives to energize the next generation, foster meaningful service, and expand HFMA's reach across the state. How are these trailblazing women redefining leadership in healthcare finance, and what does their work mean for the future of healthcare communities?On Highway to Health, host David Kemp sits down with the women in question, namely Rachel Pugliano, Jamie Hill-Walters, and Anna Stevens, to celebrate this historic moment and discuss their vision for HFMA's future.Key Takeaways from the Episode:Inclusive Engagement: Rachel Pugliano emphasizes bridging gaps across South Texas' vast geography, ensuring all members—new and seasoned—feel connected and valued.Empowering the Next Generation: Jamie Hill-Walters highlights initiatives like hands-on volunteer work, education, and certifications to attract and support emerging leaders in healthcare finance.Community in Action: Anna Stevens shares how the Gulf Coast chapter is moving beyond financial support to hands-on service, deepening ties with local organizations.About the Guests:Rachel Pugliano: Rachel Pugliano, Director at Eide Bailly, is a healthcare executive with over 20 years of experience in revenue cycle optimization and process improvement. Leveraging her clinical background, she delivers sustainable solutions and trains teams across all levels of healthcare operations. As President of HFMA's South Texas chapter, Rachel drives initiatives to enhance member engagement and inclusivity.Jamie Hill-Walters, CRCR: Jamie Hill-Walters, CRCR, is a healthcare revenue leader with over 20 years of experience driving financial growth, client engagement, and revenue cycle optimization for major U.S. healthcare systems. Currently Chief Customer Officer at Janus Health, she specializes in implementing strategies that enhance financial outcomes, process efficiency, and client relationships. As President of HFMA's Texas Lone Star Chapter, Jamie champions education, leadership development, and community engagement to advance healthcare financial management.Anna Stevens, CPA, FHFMA: Anna Stevens, CPA, FHFMA, is Partner-in-Charge of Healthcare at Weaver, where she provides assurance, compliance, and financial analysis services to healthcare organizations, including hospitals, clinics, and post-acute care facilities. A Fellow of HFMA and President of the Gulf Coast Chapter, Anna champions initiatives to strengthen healthcare financial management and foster community engagement. With experience as a Corporate Controller for a post-acute healthcare system, she has successfully managed operating budgets, financial reporting, and departmental performance, leveraging over a decade of expertise to drive operational excellence.

Send us a textUnlock the secrets to mastering healthcare finance with our insightful conversation featuring LaTasha Barnes, a trailblazer in transforming healthcare organizations. Imagine gaining the financial acumen that could redefine your leadership journey and elevate your impact in this complex industry. From her early days at Big Four audit firms to navigating the intricacies of healthcare finance, LaTasha shares her unique perspective and expertise. Together, we discuss strategies to bridge the gap between operational roles and financial understanding, offering valuable insights for directors and VPs seeking to enhance their careers and contribute more effectively to their organizations.Explore the intricacies of the healthcare reimbursement landscape and the importance of innovation in care delivery. LaTasha and I dive into the transition from director to vice president roles, shedding light on the nuances of employment contracts and bonus plans. We emphasize the role of mentorship in career growth, highlighting how seasoned guidance can help aspiring leaders navigate common pitfalls. Whether you're grappling with staffing challenges or striving for operational efficiency, our conversation offers actionable strategies and inspirational advice to support your journey in healthcare leadership.Thanks for tuning in to this episode of Follow The Brand! We hope you enjoyed learning about the latest marketing trends and strategies in Personal Branding, Business and Career Development, Financial Empowerment, Technology Innovation, and Executive Presence. To keep up with the latest insights and updates from us, be sure to follow us at 5starbdm.com. See you next time on Follow The Brand!

Prepare to expand your understanding of cybersecurity and IT procurement as we welcome Montae Brockett, the Deputy CIO and Chief Information Security Officer at Washington DC's Department of Healthcare Finance. Montae shares his expert insights on the intricate dance of integrating cybersecurity into IT procurement processes. With the evolving threat landscape in mind, we explore the strategies necessary to synchronize procurement, IT, and cybersecurity teams to meet agency needs and retain top talent, especially during Cybersecurity Month.Our conversation shifts gears as we explore the modernization of procurement offices, focusing on technological and business process advancements. Highlighting the transformative potential of generative AI, we delve into its role in streamlining operations and the complexities of contract terms and legislative landscapes. Montae's insights on these topics underscore the importance of aligning technology with organizational missions and visions, offering listeners valuable knowledge on bridging the gap between open source and commercial products.Click here to view the transcript.Follow & subscribe to stay up-to-date on NASPO!naspo.org | Pulse Blog | LinkedIn | Youtube | Facebook

Blue Cross Blue Shield CEO Sarah Iselin is a great asset for Massachusetts. I admired her work when she ran the Department of Healthcare Finance and Policy and then the BCBS Foundation, and was grateful for her rescue of Massachusetts' implementation of the Affordable Care Act. After a decade-long sojourn to Florida and California she's come back to Massachusetts just in time to address some big challenges. Among the topics we discussed:The Steward Healthcare bankruptcyAccess to care -especially behavioral healthThe health care cost crisisWomen's healthValue based care and the Alternative Quality ContractI also enjoyed learning about how Sarah was inspired by her parents to enter public service and her early dates as an art student.Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.

In this episode, Ken Kaufman, Chair of Kaufman Hall, joins Scott Becker to discuss critical trends in healthcare finance, the impact of COVID-19 on hospital operations, and the challenges of consolidation and staffing in the healthcare industry. Kaufman shares his expert insights on the evolving financial landscape and the future of healthcare delivery.

In this episode, host Dan Karnuta welcomes Nick Hut, senior editor at the Healthcare Financial Management Association. They do a deep dive into the Change Healthcare cyberattack: what happened, who was affected, temporary and long-term fixes, the impact on stakeholders — including patients — and what lessons were learned from a disaster that affected one third of Americans. Professor Karnuta is the director of the Professional Program in Healthcare Management at the Naveen Jindal School of Management at The University of Texas at Dallas. Links: HFMA's Voices in Healthcare Finance podcast

HFMA Policy Director Andrew Donahue's column, “An open letter to Congress on nonprofit hospital finances,” has struck a chord with members. In this episode, he discusses margins, investments and M&A and what measure tells the real story of hospital finance. Also in this episode, Brad talks about the recent HFMA report Curing Payment Confusion. Also mentioned in this episode: Healthcare 2030: Restoring Trust in Healthcare Assessing Reality in Healthcare Financial Information | HFMA

—--

Welcome to another episode of Passive Income Pilots, where we delve into the burgeoning world of assisted living investments. Join hosts Tate Duryea and Ryan Gibson as they discuss the impact of the demographic shift known as the "Silver Tsunami" with Dwayne Clark, founder of Aegis Living. Dwayne shares his extensive experience in building a premier brand in the senior housing industry and provides insights into the challenges and triumphs of caring for the aging population.Timestamped Show Notes:(00:00) - Introduction by Tate and Ryan, discussing the demographic trends boosting assisted living investments.(01:00) - Tate shares a personal story highlighting the immediate relevance of senior care.(02:00) - Ryan introduces Dwayne Clark, highlighting his accomplishments and the ethos of Aegis Living.(04:00) - Dwayne Clark joins the conversation, detailing his journey from the criminal justice field to senior housing.(05:00) - Discussion on the inception of Aegis Living and the challenges of funding and growing a business in senior housing.(07:00) - Dwayne reflects on the sacrifices made to establish Aegis Living, including personal financial risks.(10:00) - Exploring the demographic changes affecting senior housing and the concept of the "silver tsunami."(13:00) - Insights into the supply constraints in senior housing exacerbated by COVID-19 and its impacts on the market.(15:00) - Dwayne shares his philosophy on integrating community history and elements into the design of Aegis facilities.(17:00) - Detailed explanation of different types of senior living and care options available.(20:00) - Discussion on the investment aspects of senior housing and the importance of choosing the right management.(24:00) - Dwayne addresses how families can finance senior living through home equity and other means.(28:00) - Advice for individuals on how to discuss and plan for aging parents' future care needs.(32:00) - Ryan and Tate reflect on the operational excellence at Aegis Living.(35:00) - Dwayne discusses the role of adversity in shaping his career and approach to senior living.(38:00) - Closing thoughts on the current economic climate and its effect on the real estate and senior living sectors.Resources Mentioned:Aegis Living Website: Visit Aegis LivingDwayne Clark's Personal Website: Explore HereDwayne's upcoming book Where's Your Purse: A Guide for Children with Aging Parents details managing aging parent care.Remember to subscribe for more insights at PassiveIncomePilots.com!Join our growing community on FacebookCheck us out on Instagram @PassiveIncomePilotsFollow us on X @IncomePilotsGet our updates on LinkedInHave questions or want to discuss this episode? Contact us at ask@passiveincomepilots.com See you on the next one!Legal DisclaimerThe content of this podcast is provided solely for educational and informational purposes. The views and opinions expressed are those of the hosts, Tait Duryea and Ryan Gibson, and do not reflect those of any organization they are associated with, including Turbine Capital or Spartan Investment Group. The opinions of our guests are their own and should not be construed as financial advice. This podcast does not offer tax, legal, or investment advice. Listeners are advised to consult with their own legal or financial counsel and to conduct their own due diligence before making any financial decisions. The hosts, Tait Duryea and Ryan Gibson, do not necessarily endorse the views of the guests featured on the podcast, nor have the guests been comprehensively vetted by the hosts. Under no circumstances should any material presented in this podcast be used or considered as an offer to sell, or a solicitation of any offer to buy, an interest in any investment. Any potential offer or solicitation will be made exclusively through a Confidential Private Offering Memorandum related to the specific investment.

On this episode of Healthy Outcomes, our host Mark Ross interviews Andrew Donahue, Director of Healthcare Finance Policy at the Healthcare Financial Management Association (HFMA). Together, Mark and Andrew discuss the pivotal issues at the heart of healthcare finance such as inflation,  the implications of demographic shifts on the sector, and more, and how these issues are impacting hospital and health systems nationwide. Follow UsTwitter @bakertillyusFacebook @BakerTillyUSInstagram @bakertillyusPresented by Baker Tilly https://www.bakertilly.com/

In this episode of Minding Memory, Matt & Donovan speak with Dr. Joanne Spetz, the Brenda and Jeffrey L. Kang Presidential Chair in Healthcare Finance and Director of the Philip R. Lee Institute for Health Policy Studies at the University of California, San Francisco (UCSF). Joanne talks with Matt & Donovan about who makes up the professional workforce of people who provide dementia care and how these individuals play a critical role in the delivery of services. Joanne also discusses how different professional roles interact across setting of care. Lastly, Joanne introduces a new study she is working on with Donovan called the National Dementia Workforce Study (NDWS) that will be surveying a large group of clinicians who provide care for people living with dementia. Faculty Bio: https://profiles.ucsf.edu/joanne.spetz Article Referenced in Podcast: Candon M, Bergman A, Rose A, Song H, David G, Spetz J. The Relationship Between Scope of Practice Laws for Task Delegation and Nurse Turnover in Home Health. J Am Med Dir Assoc. 2023 Nov;24(11):1773-1778.e2. doi: 10.1016/j.jamda.2023.07.023. Epub 2023 Aug 24. PMID: 37634547; PMCID: PMC10735229. Previous Minding Memory Episodes on Dementia & Family Caregiving: S1Ep9: Caregiving for individuals with Dementia (with Amanda Leggett) S1Ep10: What is it like to be a Caregiver for a Person Living with Dementia? (with Peggy Arden) The transcript for this episode can be found here.CAPRA Website: http://capra.med.umich.edu/ You can subscribe to Minding Memory on Apple Podcasts, Spotify, Google Podcasts or wherever you listen to podcasts. Hosted on Acast. See acast.com/privacy for more information.

Adoption models, which are very popular in computing and organizational change, define stages for the adoption of a process or technology and helps organizations determine which stage they're at: piloting, early adoption, true integration into business practices, etc. After conducting in-depth research with health system finance leaders across the country, FinThrive realized there was a significant market need for an adoption model that could show the impact of technology on RCM. Their vision is for healthcare organizations to improve revenue cycle management efficiencies in the same way EHRs over the past 15 years have improved clinical processes. Check out this video interview with FinThrive's VP of Portfolio Marketing Jeff Becker and Chief Innovation Officer John Yount to learn more. Learn more about FinThrive: https://finthrive.com/ Health IT Community: https://www.healthcareittoday.com/

In this episode, we are joined by Mike Morris, the President and CEO at Xtend Healthcare, Here, we delve into the pressing challenges faced by hospitals and health systems as they navigate the healthcare landscape in 2024. Join us as we explore the critical role of technology in addressing workforce shortages, financial constraints, and revenue cycle inefficiencies.This episode is sponsored by Xtend Healthcare.

In this episode, we are joined by Mike Morris, the President and CEO at Xtend Healthcare, Here, we delve into the pressing challenges faced by hospitals and health systems as they navigate the healthcare landscape in 2024. Join us as we explore the critical role of technology in addressing workforce shortages, financial constraints, and revenue cycle inefficiencies.This episode is sponsored by Xtend Healthcare.

AI is going to change everything, today we look at Healthcare Finance.

Navigating the complexities of healthcare finance has become increasingly vital as hospitals and healthcare systems face multifaceted financial challenges. The pressure is mounting from the intricacies of managed care to the nuances of patient billing. Declining revenue and lower-than-average payment recoupment, coupled with increased expenses over the past few years due to the global pandemic, created a perfect storm, leading to a rise in hospital closures.How do healthcare professionals navigate this intricate financial maze?In the latest episode of I Don't Care, host Kevin Stevenson sits down with Dr. Cristian Lieneck, Ph.D., a Professor at Texas State University and an expert in healthcare finance, to unravel the subject's complexities.Key discussion points include:• The challenges of determining true healthcare costs and setting appropriate charges• The impact of pay for performance and the implications of Medicare's strategies on commercial payers• The increasing trend of managed care organizations acquiring physician practices and its implicationsAbout Dr. Cristian Lieneck:Dr. Lieneck is a professor at Texas State University and an award-winning educator and researcher. With over a decade of experience in both graduate and undergraduate programs in health administration, he brings a wealth of knowledge from his time as a practitioner in the field. Dr. Lieneck's journey into health administration began with the army, where he served in various capacities, including running a field evacuation unit and overseeing dental clinics.

Navigating the complexities of healthcare finance has become increasingly vital as hospitals and healthcare systems face multifaceted financial challenges. The pressure is mounting from the intricacies of managed care to the nuances of patient billing. Declining revenue and lower-than-average payment recoupment, coupled with increased expenses over the past few years due to the global pandemic, created a perfect storm, leading to a rise in hospital closures.How do healthcare professionals navigate this intricate financial maze?In the latest episode of I Don't Care, host Kevin Stevenson sits down with Dr. Cristian Lieneck, Ph.D., a Professor at Texas State University and an expert in healthcare finance, to unravel the subject's complexities.Key discussion points include:• The challenges of determining true healthcare costs and setting appropriate charges• The impact of pay for performance and the implications of Medicare's strategies on commercial payers• The increasing trend of managed care organizations acquiring physician practices and its implicationsAbout Dr. Cristian Lieneck:Dr. Lieneck is a professor at Texas State University and an award-winning educator and researcher. With over a decade of experience in both graduate and undergraduate programs in health administration, he brings a wealth of knowledge from his time as a practitioner in the field. Dr. Lieneck's journey into health administration began with the army, where he served in various capacities, including running a field evacuation unit and overseeing dental clinics.

Rick Warren, Chief Financial Officer & Chief Operating Officer, Innovation Care Partners, brings lessons from more than 25 years in Healthcare Finance. This includes roles as senior finance and FP&A roles at Ascension (one of the one of the largest private healthcare systems in the United States), Banner Health, one of the largest nonprofit health care systems in the country, and CVS Health, one of the US's largest retail pharmacy store chains. This is a must-listen for anyone who is interested in finance procedures in healthcare and the most important metrics in healthcare for anyone in finance.   This episode covers:  How finance can help transform healthcare equity –  the challenge of getting lower socioeconomic group fair  healthcare coverage Rick Moving from a political science degree to finance and ultimately CFO The importance of Relevance over precision in FP&A The nightmare budget which crashed before it was saved Lessons from Boy Scout leadership positions  Margins for hospitals still struggling post-covid  The fundamental healthcare financial metrics including reducing hospital expenses, admissions per thousand, ER visits vs primary health care physician, SNF nursing home days spent, revenue and expense per member per month  The secrets to effective business partnerships in FP&A Favorite Excel Function FP&A Today is brought to you by Datarails,the AI-powered financial planning and analysis platform.  Keep your own Excel financial models and spreadsheets and benefit from AI for data consolidation, reporting and planning.

Prior authorization. It's a dreaded phrase for patients and providers alike. Now some health plans like Cigna say they're cutting back on the practice, and the feds are contemplating restrictions, too. What is prior authorization in healthcare? And can the US healthcare system live without it?ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterShop official CareTalk merchFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedIn#healthcare #healthinsurance #priorauthorization #healthcarefinance #healthcareeconomics #healthcarepolicy #healthcarebusiness  #digitalhealthCareTalk: Healthcare. Unfiltered. is produced by Grippi Media

Having started 46 Labs servicing carrier communication problems,46 Labs soon realized that large enterprise had very similar problems. Trevor Francis, CEO of 46 Labs, discusses with Don Witt of The Channel Daily News how they were able to support both channels fixing anything that would break in communications. It was not long before 46 Labs was able to assemble a complete platform called Peeredge. Trevor provides two examples of how their technology is integrated into a carrier's network and how they integrate their technology into enterprise as well. Trevor Francis Carriers and enterprises find Drag and Drop automation, push-button technology, global infrastructure, Peeredge and working with major organizations around the world to establish voice connectivity are standout features of 46 Labs. Trevor will also discuss the reason that telecom companies use SaaS and the cyber security risks associated with SaaS technology. This is good technology and it will help those carriers and enterprise that are short staffed, short on internal technical capabilities and may also need a network overhaul. 46 Labs is the world's connectivity orchestration company. IT leaders harness their trusted Peeredge™ platform to bring together and interconnect the foundational infrastructure that powers their success - all while orchestrating connectivity sustainably and securely. 46 Labs Orchestrates the World's Connectivity™. Digital leaders harness their automation platform and team of experts to orchestrate the foundational elements that power their global success. They enable their clients to ease their operational burdens and expand their reach across any connectivity medium. For more information, go to: www.46labs.com or call +1 (888) 646-5227

Congress's failure to raise the debt limit has brought the US perilously close to default. Republicans have insisted on major cuts to federal spending –including in healthcare—in exchange for their votes. President Joe Biden and House Speaker Kevin McCarthy worked out an agreement in principle, which gives in, at least partially, to the GOP demands while preserving Democratic priorities. So, what's the impact of the debt ceiling deal on healthcare? Will the deal have a real impact or is it all just smoke and mirrors?ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedInSubscribe to the CareTalk Newsletter to access exclusive content and insights covering the biggest topics in healthcare today. Check out the CareTalk Store for official merch. Produced by Grippi Media

It finally happened! CareTalk and Dr. Eric Bricker (AHealthcareZ), two titans of healthcare YouTube, join forces to take on some of the juiciest topics in healthcare finance and more.

Rural communities have fewer doctors, nurses and medical facilities per person than the country as a whole. Some rural hospitals have closed, leaving large geographic areas without local services. And the population is older, sicker, more likely to have unhealthy habits like tobacco use and less likely to have access to reliable transportation to get to their appointments. Rural healthcare is a challenge. But is it all doom and gloom? John and David share their thoughts.TOPICS(1:20) Reviewing the statistics on rural health(1:57) Do social determinants of health contribute to rural health(5:42) Challenges rural health faces(7:09) The difference in healthcare delivery (12:25) What's going on with rural hospital closures?(15:16) Opportunities to innovate emergency servicesABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHBecome a CareTalk sponsorGuest appearance requestsVisit us on the webFOLLOW CARETALKSpotifyApple PodcastsGoogle PodcastsFollow us on LinkedInSubscribe to the CareTalk Newsletter to access exclusive content and insights covering the biggest topics in healthcare today. Produced by Grippi Media

Offering financing options can make all the difference in gaining new patients and providing the necessary treatments they may have otherwise avoided. In this episode, Eric and Brett discuss how United Credit empowers merchants to build their businesses through financing.

Preston Hodapp, Director of Patient Access talks about Patient Access at Phelps Health. He speaks about the Patient Access Department, as well as access to care and financials.

July 18, 2022: https://www.linkedin.com/in/charlesboicey/ (Charles Boicey) from https://clearsense.com/ (Clearsense) joins Bill for the news today, and wow, do they cover a lot. The Metaverse and virtual reality are gaining a foothold in healthcare and Charles shares his personal experience with investing in the Metavers universe. 86% Of Medical Alert System Users Say The Devices Have Helped Save Them From An Incident. CMS Issues Proposed Rule for Rural Emergency Hospitals. Synaptic Health Alliance provider data blockchain initiative expands. Hospitals see challenges around price transparency, technology and resources. How can RTLS security protect healthcare workers and reduce burnout? Key Points: Are we getting better with satellite communication in regards to latency?  If we don't overcome the rural healthcare challenge, we will see urban centers get overrun Blockchain in healthcare is over the hype cycle https://clearsense.com/ (Clearsense) Stories: https://www.healthcarefinancenews.com/news/metaverse-and-virtual-reality-are-gaining-foothold-healthcare (Metaverse and virtual reality are gaining a foothold in healthcare - Healthcare Finance) https://www.forbes.com/health/healthy-aging/medical-alert-systems-survey/ (86% Of Medical Alert System Users Say The Devices Have Helped Save Them From An Incident - Forbes) https://www.hcinnovationgroup.com/policy-value-based-care/health-equity/news/21273031/cms-issues-proposed-rule-for-rural-emergency-hospitals (CMS Issues Proposed Rule for Rural Emergency Hospitals - Healthcare Innovation) https://www.healthcarefinancenews.com/news/synaptic-health-alliance-provider-data-blockchain-initiative-expands (Synaptic Health Alliance provider data blockchain initiative expands - Healthcare Finance) https://www.healthcarefinancenews.com/news/hospitals-see-challenges-around-price-transparency-technology-and-resources (Hospitals see challenges around price transparency, technology and resources - Healthcare Finance) https://www.healthcareitnews.com/news/how-rtls-security-can-protect-healthcare-workers-and-reduce-burnout (How RTLS security can protect healthcare workers and reduce burnout - Healthcare It News)

The recently signed gun law, S. 2938: Bipartisan Safer Communities Act, contained a surprise dingleberry postponing a regulation designed to save seniors money on their pharmaceutical drugs by prohibiting kickbacks to an industry few have heard of: Pharmacy Benefit Managers (PBMs). This little-known but extremely powerful industry deserves much of the blame for ever rising prescription drugs costs in the United States. In this episode, Jen gives you the scoop on PBMs and how they make their money at the expense of Americans who are most dependent on medications. Please Support Congressional Dish – Quick Links Contribute monthly or a lump sum via PayPal Support Congressional Dish via Patreon (donations per episode) Send Zelle payments to: Donation@congressionaldish.com Send Venmo payments to: @Jennifer-Briney Send Cash App payments to: $CongressionalDish or Donation@congressionaldish.com Use your bank's online bill pay function to mail contributions to: 5753 Hwy 85 North, Number 4576, Crestview, FL 32536. Please make checks payable to Congressional Dish Thank you for supporting truly independent media! View the shownotes on our website at https://congressionaldish.com/cd255-pharmacy-benefit-managers-pbms We're Not Wrong Berlin Meetup Contact Justin at WereNotWrongPod@gmail.com Background Sources Recommended Congressional Dish Episodes CD134: The EpiPen Hearing US Healthcare Landscape Jessi Jezewska Stevens. Apr 23, 2020. “A Brief History of the Great American Healthcare Scam.” Bookforum. Tanza Loudenback. Mar 7, 2019. “The average cost of healthcare in 21 different countries.” Insider. Chuck Grassley and Ron Wyden. 2019. “Insulin: Examining the Factors Driving the Rising Cost of a Century Old Drug [Staff Report].” U.S. Senate Finance Committee. “Health Insurance Coverage of the Total Population.” Kaiser Family Foundation. Sara R. Collins and David C. Radley. Dec 7, 2018. “The Cost of Employer Insurance Is a Growing Burden for Middle-Income Families.” The Commonwealth Fund. PBMs What are PBMs? JC Scott. Jun 30, 2022. “Drug manufacturers are root cause of high drug costs; PBMs drive costs down.” The Hill. Zach Freed. Jun 22, 2022. “The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists.” American Economic Liberties Project. Adam J. Fein. Jun 22, 2021. “The Top Pharmacy Benefit Managers of 2020: Vertical Integration Drives Consolidation (rerun).” Drug Channels. “Flash finding: How drug money from sick people really works.” Nov 11, 2021. 46brooklyn. Adam J. Fein. Feb 3, 2019. “Don't Blame Drug Prices on ‘Big Pharma.'” The Wall Street Journal. How PBMs Make Money “DIR Fees.” National Association of Chain Drug Stores. “How PBMs Make Money: PBM Practices & Profits.” RxSafe. True North Political Solutions. Oct 25, 2017. “White Paper: DIR Fees Simply Explained.” Pharmacy Times. ACA “Vertical Integration” Loophole Peter High. Jul 8, 2019. “A View From Inside Cigna's $67 Billion Acquisition Of Express Scripts.” Forbes. Angelica LaVito. Nov 28, 2018. “CVS creates new health-care giant as $69 billion merger with Aetna officially closes.” CNBC. David Dayen. Oct 12, 2018. “Why the Aetna and CVS Merger Is So Dangerous.” The American Prospect. Jeff Byers. April 12, 2018. “Optum a step ahead in vertical integration frenzy.” Healthcare Dive. Graph: Optum opens up wider market for UnitedHealth Group Graph: Optum's pharmacy business contributes the majority of its revenue Susan Morse. May 10, 2017. “Secret weapon: UnitedHealth's Optum business is laying waste to old notions about how payers make money.” Healthcare Finance. Lobbying “Client Profile: Pharmaceutical Care Management Assn.” Open Secrets. The Demise of Independent Pharmacies Christine Blank. Oct 17, 2019. “Independents Prepare to Close Up Shop.” Drug Topics. Paulina Firozi. Aug 23, 2018. “The Health 202: Here's why rural independent pharmacies are closing their doors.” The Washington Post. What Is a Formulary? Ana Gascon Ivey. May 19, 2020. “A Guide to Medication Formularies.” GoodRx. Previous Delays in Rebate Regulation Paige Minemyer. Jan 29, 2021. “In a win for PBMs, Biden administration delays rebate rule.” Fierce Healthcare. Paige Minemyer. Jan 12, 2021. “PCMA sues Trump administration over rebate rule.” Fierce Healthcare. “Incorporating the Effects of the Proposed Rule on Safe Harbors for Pharmaceutical Rebates in CBO's Budget Projections—Supplemental Material for Updated Budget Projections: 2019 to 2029.” May 2019. Congressional Budget Office. The Gun Law Passage Process Office of the Clerk. May 18, 2022. “Roll Call 212 | Bill Number: S. 2938.” U.S. House of Representatives. Tampa Bay Times Editorial Board. May 12, 2022. “Republican lawmakers should be ashamed for failing to honor Justice Joseph Hatchett.” Miami Herald. Annie Karni. Apr 12, 2022. “House G.O.P., Banding Together, Kills Bid to Honor Pioneering Black Judge.” The New York Times. Background on Most Important Provisions Mary Katherine Wildeman. May 26, 2022. “Data show most school shootings carried out by young adults, teens.” CT Insider. Jeffrey Pierre. May 26, 2022. “Experts say we can prevent school shootings. Here's what the research says.” NPR. The Dingleberry Erik Sherman. Jun 30, 2022. “Gun Safety Bill Extends Drug Middlemen Protection From Anti-Kickback Measure.” Forbes. Molly Rutherford. Jun 28, 2022. “Gun legislation provision puts drug supply chain profits over patients.” The Hill. Marty Schladen. Jun 22, 2022. “Deep inside the gun bill: a break for prescription drug middlemen.” Iowa Capital Dispatch. Poland Train Station Taylor Popielarz, Maureen McManus and Justin Tasolides. Mar 25, 2022. “‘The help given is remarkable': Inside the Poland train station that's become a hub for Ukrainian refugees.” Spectrum News NY1. The Law and the Regulation S. 2938: Bipartisan Safer Communities Act Senate Vote: 65-33 (All Nos GOP) House Vote: 234-193 (All Nos GOP) Jen's Highlighted PDF of S. 2938: Bipartisan Safer Communities Act Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees U.S. Health and Human Services Department November 30, 2020 Audio Sources The State of Competition in the Pharmacy Benefits Manager and Pharmacy Marketplaces November 17, 2015 House Committee on the Judiciary Witnesses: Bradley J. Arthur, R.Ph., Owner, Black Rock Pharmacy David Balto, Law Offices of David A. Balto PLLC Amy Bricker, R.Ph. Vice President of Retail Contracting & Strategy, Express Scripts Natalie A. Pons, Senior Vice President and Assistant General Counsel, CVS Health Clips 53:48 Bradley Arthur: The Big Three PBMs control almost 80% of the entire market and these PBMs have the upper hand both in negotiating the contract with the payer, as well as strongly influencing the actual plan design itself. The PBM industry typically states that they can use their economic power to harness enhanced market efficiencies, but for whom? However, the staggering annual revenues that continue to grow each year of the big three suggests that these efficiencies are going directly to their corporations' bottom lines. Small community pharmacies like mine are faced on a daily basis with the impact of the PBMs' disproportionate market power. Community pharmacies routinely must agree to take-it-or-leave-it contracts from the PBMs just to continue to serve our long-standing patients. As if that weren't enough, the PBMs also directly set the reimbursement rates for pharmacies, the very same pharmacies that stand in direct competition of some of these PBM-owned mail-order and specialty pharmacies. Therefore, it comes as no surprise that the PBMs present employer and government payers with carefully tailored suggested plans designs that steer beneficiaries to these PBM-owned entities. Drug Pricing in America: A Prescription for Change, Part I January 29, 2019 Senate Committee on Finance Witnesses: Kathy Sego, Mother of a Child with Insulin-Dependent Diabetes Douglas Holtz-Eakin, Ph.D., President, American Action Forum Mark E. Miller, Ph.D., Vice President of Health Care, Laura and John Arnold Foundation Peter B. Bach, MD, MAPP, Director, Memorial Sloan Kettering Center for Health Policy and Outcomes Clips 1:57:30 Sen. John Cornyn (R - TX): Can anybody on the panel explain to me why we have a general prohibition against kickbacks — they call them rebates — under the Social Security Act, but we nevertheless allow it for prescription drug pricing? What's the sound public policy reason for excluding prescription drug pricing from the anti-kickback rule under federal law? Douglas Holtz-Eakin: I can't explain that and won't pretend to. [laughter] Sen. Cornyn: I thought I was the only one who didn't understand the wisdom of that. Well, it's not a transparent arrangement and it does produce upward pressure on drug prices. And obviously, the negotiations between the PBM and the pharma in terms of what the net cost is, is not transparent, nor is it delivered to the consumer. Is it Dr. Miller? Dr. Bach? Peter Bach: It's delivered to the consumer indirectly through the reduction of the total cost of the benefit, but it is not delivered to the actual consumer using the drug, and that is a disassociation, that is a problem. Because it essentially reverses the structure of insurance. Lowering the total costs are people who use it the least, and raising the costs are people who use it the most, relative to if you allowed the rebate to be used at the point of sale, including all discounts. 1:59:49 Douglas Holtz-Eakin: If we had the negotiation be about the upfront price, so instead of a high list price and a rebate, you just negotiate a lower price, that would be the price that Ms. Sego would pay and insurance companies would look at that and say, okay, she's not paying as much as she used to, we're going to have to make up that money somewhere else and they might raise premiums. That means that people who don't have extreme insulin drug costs would pay a little bit more in a premium every month, and people who have extremely devastating medical conditions and high health care costs would get less costs. That's exactly what insurance is supposed to do. And so the rebate system is more than giving strange incentives on pricing. It's undercutting the purpose of insurance in general. Drug Pricing in America: A Prescription for Change, Part II February 26, 2019 Senate Committee on Finance Witnesses: Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc. Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals, Johnson & Johnson Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc. Albert Bourla, DVM, Ph.D., Chief Executive Office, Pfizer Olivier Brandicourt, M.D., Former Chief Executive Officer, Sanofi Clips 1:22:03 Albert Bourla: Adverse incentives that favor higher cost biologics are keeping biosimilars from reaching patients. In many cases, insurance companies declined to include lower cost biosimilars in their formularies because they would risk losing the rebates from covering higher cost medicines. I can't think of a more concerning example of a broken system and we need to do something about it. 1:33:35 Sen. Chuck Grassley (R - IA): So many of you have voiced support for the recent rebate rule proposed by the administration. Should the administration finalized this rule, will you commit to lowering your drug prices? Richard Gonzalez [CEO, AbbVie]: Mr. Chairman, we are supportive of the rule. We'd like to see it in its final form, obviously, to make a final decision, but we are supportive of taking the discount to the patient at the point of sale. Sen Grassley: Okay. AstraZeneca? **Pascal Soriot [CEO, AstraZeneca]**The same for us Senator, I would go one step further: if the rebates were removed from the commercial sector as well, we will definitely reduce our list prices. Sen Grassley: Okay. And Bristol? Giovanni Caforio [CEO, Bristol-Myers Squibb]: We have the same positions. Sen Grassley: Okay. Johnson and Johnson? Jennifer Taubert [EVP, J&J]: Yes, we're supportive, and that definitely would be my goal. We would just need to see the final legislation, provided that there aren't additional fees that are added into the system to compensate for the rebates. Sen Grassley: Merck? **Kenneth C. Frazier: I would expect that our prices would go down if we change the system. Again, on the commercial side as well as the Medicare side. Sen Grassley: Okay, Pfizer? Albert Bourla [CEO, Pfizer]: It is a very clear intention that we will not keep a single dollar from these rebates. We will try to move every single penny to the patients and we think if this goes also to the commercial plants that will be even better for more patients. Sen Grassley: Okay. Sanofi? Olivier Brandicourt [Former CEO, Sanofi]: Lowering list price has to be linked to better access and affordability at the counter for the patients. 1:35:20 Sen. Ron Wyden (D - OR): Is it correct that your company, and nobody else, sets the starting price for all drugs sold by Pfizer? Yes or no? Albert Bourla: It is a negotiation with PBMs and they are very powerful. Sen. Wyden: But you still get to set the list price? Albert Bourla: Yes, but we set this price and the rebate limit(?). 1:35:40 Sen. Ron Wyden (D - OR): Is it correct, when a hypothetical patient, let's call her Mrs. Jones, goes to pay for her drug at the pharmacy counter, her coinsurance is based on the price of the drug you set? Albert Bourla: It is correct in many cases. Sen. Wyden: Okay. I just want you all to know that the number one reason consumers are getting hammered, is because these list prices, which you have the last word with respect to where they are, are unaffordable. And the high prices are tied to what the consumer pays at the pharmacy counter. And all this other stuff you talk about, the rebates and the discounts and the coupons, all this other stuff is window dressing, all of that. And the fact is on Part D, 40% of the drugs don't even have a rebate. So I want it understood, particularly because I've asked you, Mr. Borla, I think you and others in the industry are stonewalling on the key issue, which is actually lowering list prices. And reducing those list prices are the easiest way for American consumers to pay less at the pharmacy counter. 2:12:45 Sen. Thomas Carper (D-DE): First is eliminating rebates to PBMs. That's the first one, eliminating rebates to PBMs. The second is value based arrangements. And the third is increasing transparency industry-wide on how you set your prices. 2:13:20 Richard Gonzalez: We clearly support providing the discount at the patient level, eliminating rebates essentially. 2:14:10 Pascal Soriot: If the rebates, as I said earlier, were to be removed from Part D and the commercial sector, we would actually reduce our list prices. 2:15:10 Giovanni Caforio: I would say that not only do we support all three elements that you mentioned, but I do believe those three elements together with the continued effort to develop a generic and biosimilar market would mean significant change, and would clearly alleviate the concerns that patients have today. 2:14:44 Jennifer Taubert: We are very supportive of all three elements that you outlined 2:15:52 Kenneth Frazier: We too support all three. 2:15:55 Albert Bourla: All three elements are transformational for our industry, will disrupt it. However, we do agree that these are the three things that need to be done and also I believe that will have significant meaningful results if we do. 2:16:10 Olivier Brandicourt: We support the three Senator, but we want to keep in mind at the end of the chain the patient has to benefit, so if rebates are removed it has to be to the benefit of patients. Sen. Thomas Carper (D-DE): Good, thanks. 2:18:10 Albert Bourla: 50% of the American people are in commercial plans and these rebate rules apply to Medicare. If the rules apply to all, definitely the list price will go down. 2:18:30 Albert Bourla: The list price is not irrelevant, it's very relevant for a lot of people because they have to pay list price during the deductible period. However if the rebate rule is applied, then they become irrelevant because the patients will not be paying the list price at the purchase point. 2:19:10 Sen. John Thune (R-SD): How would manufacturers respond if the rebate rule were finalized for government programs? I mean, what does that what does that mean for the commercial market? Albert Bourla: Senator, as I said before, all these proposals that they're discussing, [undistinguishable], eliminating the rebate rule, are transformational and will disrupt the way we do business. I don't know exactly how the system will evolve, and I really don't favor a bifurcated system. I would like to have a transparent single system across both parts. So we need to see how the whole thing will evolve. 2:25:26 Johnny Isakson (R-GA): Who sets the discount and who sets the rebate? 2:26:20 Richard Gonzalez: We negotiate with payers, so managed care and PBMs— Sen. Johnny Isakson (R-GA): You're a supplier though, so you have to go negotiate with the PBMs and those people, is that right? Richard Gonzalez: Correct, and they negotiate aggressively. Sen. Isakson: Is that pretty much true with everybody, that they're the major component between the end retail consumer price and the origin of the product? Richard Gonzalez: Yes, Senator. Sen. Isakson: Well, that seems like that's someplace we ought to focus, because that's where the distorted numbers come in. Johnson & Johnson, Janssen, in your testimony, you talked about your average list price of 8.1%, up, but an average net price change of only 4.6%. So while your gross went up 8.6, your net went down 4.6 In the same pricing period. How does that happen? If you're setting the price, how does it not go up on the bottom? Jennifer Taubert: Yeah, and in fact, in 2018, our net price actually declined 8.6%, so even more than that. The intermediaries in the system are very, very effective negotiators— Sen. Isakson: Tell me who the intermediaries are. Jennifer Taubert: Those would be the PBMs and the insurers. Sen. Isakson: …and the insurance companies? Jennifer Taubert: Right, and they set the formularies for patients. Sen. Isakson: And they're not the same. They're two different people? Jennifer Taubert: Yes, correct. 2:40:45 James Lankford (R-OK): All of you have mentioned the rebate issue has been a problem and that insurance companies and PBMs are very effective negotiators. Part of the challenge of this is, health insurance companies pay their PBM based on the quality of their negotiation skills, cutting a price off the list price. And so if a list price is higher and a rebate is higher, that also gives preference to them. So the difficulty is, as you raise list price, and the rebate gets larger, the insurance company gives that preference, making it harder for biosimilars. Am I tracking this correctly? 2:43:00 Albert Bourla: Here in the US, the penetration of biosimilars is much lower than in other places, but it is disproportional to different parts of the US healthcare system. For example, in open systems, systems where the decision maker it is a PBM, the one biosimilar we have has a market share of 5% in the US. In closed systems, in systems like Kaiser, for example, integrated healthcare systems where the one who decides has the whole cost of the healthcare system in its interest, we have 73%. 5% and 73% for the same product. I agree with what Mr. Fraser said that we need to create incentives, but I would add also that we need to break this rebate trap that creates significant disincentives for providers, and the healthcare system, and insurance companies. 3:19:25 Kenneth Frazier: If you went back a few years ago, when we negotiated to get our drugs on formulary, our goal was to have the lowest copay by patients. Today the goal is to pay into the supply chain the biggest rebate, and so that actually puts the patient at a disadvantage since they're the only ones that are paying a portion of the list price. The list price is actually working against the patient. 3:19:50 Sen. Steve Daines (R-MT): Why do we have a system today? Where you all are setting, I'll just say very, very high list prices, which is the starting point for negotiation. Why? Olivier Brandicourt: Senator, we're trying to get formulary position. With those list prices. High list price, high rebates. It's a preferred position. Unfortunately the preferred position doesn't automatically ensure affordability at the end. Kenneth C. Frazier: Senator, If you bring a product to the market with a low list price in this system, you get punished financially and you get no uptake because everyone in the supply chain makes money as a result of a higher list price. Drug Pricing in America: A Prescription for Change, Part III April 9, 2019 Senate Committee on Finance Witnesses: Steve Miller, MD, Former Executive Vice President and Chief Clinical Officer, Cigna Corporation Derica Rice, Former Executive Vice President and President, CVS Health and CVS Caremark William Fleming, Pharm.D., Segment President, Healthcare Services, Humana Inc. John Prince, Chief Executive Officer, OptumRx Mike Kolar, JD, Interim President & CEO, Senior Vice President and General Counsel, Prime Therapeutics LLC Clips Sen. Ron Wyden (D - OR): Pharmaceutical Benefit Managers first showed up decades ago, back when prescription drugs were being utilized more extensively. The PBMs told the insurance companies, “we're the ones who know drug pricing, we will handle the negotiations for you.” But there is little evidence that the pharmaceutical benefit managers have actually held down the prices in a meaningful way. In fact, most of the evidence shows just the opposite. Pharmaceutical Benefit Managers actually make more money when they pick a higher price drug over a lower price drug. Colleagues, let's remember that all the way through this discussion, benefit managers make more money when they pick a higher price drug over a lower price drug. The logic on this isn't exactly complicated, graduate-level economics. PBM profits are based on taking their slice of the prescription-drug pie. More expensive drugs means there's a bigger pie. When there's a bigger pie, [there are] bigger slices for the pharmaceutical benefit managers. 50:24 Mike Kolar: Rebates and the role they play have been key areas of focus in the drug cost debate. In our view, rebates are a powerful tool to offset high prices, which are set by pharmaceutical companies, and pharmaceutical companies alone. The fact that rebates are not offered on many of the highest cost drugs, and that studies show no correlation between prices and rebates underscore that rebates are a key to mitigating rather than causing high drug prices. We pass rebates through fully to our plans, and we believe our plans should be able to choose how to apply these rebates in ways that best serve their members and market needs by balancing premiums and cost sharing. 56:05 Sen. Chuck Grassley (R-IA): I'd like to talk about consolidation, including the recent integration of PBMs with insurance companies. Last year I wrote to the Justice Department on the issues, it reported that the three largest PBMs who are before us today now covers 71% of Medicaid, Medicare Part D enrollees and 86% of standalone Drug Plan enrollees. 57:45 Derica Rice: This is a highly competitive space. In addition to the three that you've pointed out here, CMS has noted there are over 60 PBMs across the US. Therefore, the competition, there's many options for the employers that are out there, government entities, as well as unions to choose from given their specific needs. 1:10:35 Sen. Debbie Stabenow (D-MI): So when we look at Express Scripts has 100 million Americans covered, CVS 90 million, OptumRx 65 million, Prime Therapeutics 27 million, Humana 21 million, and yet Americans still pay the highest prices in the world. Even though you are negotiating for millions of people. The VA has its own pharmacy benefit manager service, they negotiate for 9 million veterans, and they pay, on average, 40% less for the same drugs that the rest of the healthcare system pays for. Despite greater volume, you are unable to secure these kinds of low prices. With all due respect, you guys are pretty bad negotiators. Given the fact that the VA can get 40% less. And so I'd like to know from each of you why that's the case. Dr. Miller? Steve Miller [Former EVP and Chief Clinical Officer, Cigna Corporation]: Yes. Part of the equation is giving patients choice. At the VA, they actually limit their formulary more than any of us at this table do. So oftentimes, they'll have one beta blocker, one ace inhibitor. And so if it's going to get to that level of choice, then we could get better prices also. Sen. Stabenow: Let me jump in, in the interest of time. I know you create nationwide drug formularies, you have pre-authorization, you give preferred status to certain medications. So you don't use any of those tools that the VA is using? Because you do. Steve Miller: We definitely use those tools, but we also give people choice. It's crucial for both physicians and patients to have the choice of the products they want to be able to access. Many of our plans want us to have broad formularies and when you have more products, it means you move less market share. Sen. Stabenow: So basically you're saying a 40% premium gives them more choice. 1:24:30 Sherrod Brown (D-OH): If the administration's rebate rule were finalized as proposed, would you in some way be required to change the way you do business? Mike Kolar: Yes, Senator we would. John Prince: Yes. William Fleming: Yes. Derica Rice: Yes. Steve Miller: Yes. Sen. Brown: Thank you. 1:25:05 Sherrod Brown (D-OH): What percentage of prescriptions that you fill across Part D actually receive a rebate? Roughly what percentage? Mike Kolar: So Senator, approximately 8% of the prescriptions that we cover in Part D are associated with a rebate. Sen. Brown: Okay, Mr. Prince? John Prince: Senator, I don't know the exact number, I know our overall business is about 7%. Sen. Brown: Okay, thank you. William Fleming: About 7-8%. Derica Rice: Senator, I do not know the exact number but we pass through 100% of all rebates and discounts. Sen. Brown: [Grunt] Steve Miller: 90% of the prescriptions will be generic. Of the 10% that are branded, about two-thirds have rebates. So it's about seven-- Sen. Brown: 7-8% like the others. Okay. To recap, PBMs do not set drug prices. Forcing you to change the way you do business -- as the administration's rule would — will not change that fact. And while the rule might impact a small percentage of drugs and Part D that receive a rebate, it does nothing to lower costs, as your answer suggests, for the other 90% of prescriptions you fill. Most importantly, absolutely nothing in the proposed rule would require Secretary Azar's former employer or any other pharma company to lower the price of insulin or any other drug. It's important to establish that, so thank you for that. 1:41:40 Catherine Cortez Masto (D-NV): Let me ask you, Dr. Fleming, in your testimony, you say Humana's analysis of the rebate rule -- and we're talking about the administration's rebate rule now — found that approximately 17% of beneficiaries will see savings at the pharmacy counter as a result of this rule. Can you tell me a little bit more about who these people are? And what kind of conditions do they have? William Fleming: Senator, there will be a number of members who are taking brand drugs for which we get rebates and so it could vary all the way from the common chronic conditions, things like diabetes or hypertension or high cholesterol, all the way over to occasionally, not usually, but occasionally on the specialty drug side. When you think of some medications like treatments for rheumatoid arthritis, multiple sclerosis, places where there's competition. Cover Art Design by Only Child Imaginations Music Presented in This Episode Intro & Exit: Tired of Being Lied To by David Ippolito (found on Music Alley by mevio)

The Body of Evidence is releasing an episode of HFMA's Voices in Healthcare Finance podcast, which features an interview with Dr. Christopher Labos on the topic of weight bias in healthcare, including what health indicators to focus on instead of weight and how to help patients who are at risk improve their health outcomes without explicit or implicit fat shaming.   If you enjoy Voices in Healthcare Finance, you can find the show and subscribe to it here: https://hfma.podbean.com/     To contribute to The Body of Evidence, go to our Patreon page at: http://www.patreon.com/thebodyofevidence/.   Patrons get a bonus show on Patreon called “Digressions”! Check it out!

Healthcare reimbursement models are ever-changing which requires the industry to seek out diversity in thought and experience to stay fiscally resilient in challenging times.  LaTasha Barnes understands the importance of financial operations to meet the needs of taking care of people. Resiliency in a highly competitive industry during challenging times has led her to see the healthcare system holistically when making key decisions.  Patient flow and care continuum are paramount and top of mind when assessing supply utilization, patient acuity, industry benchmarks and key performance indicators.  “ The numbers don't always tell the whole story. You must understand the business operations to be an effective financial executive.  Says LaTasha BarnesBe intentional when framing opportunities in healthcare finance Alternative career experiences can make you special because it gives you differentiation!   As chief financial officer (CFO) of Bayfront Health St. Petersburg, LaTasha Barnes oversees all financial operations for the 480-bed regional hospital. Previously, she was CFO of Orlando Health Winnie Palmer Hospital for Women & Babies and Orlando Health Arnold Palmer Hospital for Children from 2018-to 2020 and played a leading role in financial, operational, and strategic initiatives for the organization.LaTasha has more than 20 years of experience in healthcare finance. Before joining Orlando Health, she held leadership positions with Hospital Corporation of American (HCA), most recently as CFO of Tampa Community Hospital. An experienced CPA, she also is a former auditor for Arthur Andersen and Deloitte & Touche.She earned a bachelor's degree in accounting from Tennessee State University in Nashville and holds CPA licenses in both Florida and Tennessee.LaTasha is a member of the National Association of Black Accountants and has served on the board of directors for Central Florida Community Arts, Girls on the Run Central Florida, and the African American Chamber of Commerce Central Florida and was recently chosen as a nominee as Business Woman of the Year honoree.Let us welcome LaTasha Barnes to the Follow The Brand podcast where we are building a 5 STAR Brand that you can follow! https://www.orlandohealth.com/www.5starbdm.com

Voices in Healthcare Finance presents The Body of Evidence, a podcast from Dr. Christopher Labos and Jonathan Jarry.    In this episode, hosts Jarry and Labos speak with Dr. Barbara Hofer and Dr. Gale Sinatra, the authors of the book Science Denial: Why It Happens and What to Do About It.

TakeawaysThe new villain in town: OmicronAs the first cases of the COVID-19 Omicron variant appear in the U.S., media and the public speculate whether or not we'll see another wave of shutdowns.Will Omicron match the severity of the Delta variant? Is the media overstating the new variant's threat? How long will new variant cycles impact society? These are the questions that sit top-of-mind for The No Normal team.While serious questions about Omicron remain, The No Normal team couldn't help but chuckle at the variant's name choice.The World Health Organization (WHO) explained that they skipped "Nu" because it sounded too much like "new" and "Xi" to avoid offense to cultures who commonly use "Xi" as a surname, which makes sense. Yet, why did they deviate from the Greek alphabet to name the variant Omicron? Great question. A review of "The Funnel Wars"In early January 2022, Revive is releasing a new book, Joe Public 2030, which makes five bold predictions about the future of consumer health engagement. This episode covers trend number three, “The Funnel Wars.”The Funnel Wars refers to competition in the acuity funnel. The top of the funnel is one of the most common funnel entry points. It includes urgent care, virtual care, minute clinics, and even primary care.Middle-of-the-funnel services like specialty care and surgeries are much more lucrative than top-of-the-funnel services, yet depend on lower acuity touchpoints to feed patient volume. Without a full top-of-the-funnel, health systems won't be able to feed volumes for more profitable services.Competition for lower-acuity, top-of-the-funnel services is heating up as giants like CVS, Walgreens, Optum, Walmart Health, Apple, and Amazon bolster their consumer health offerings.If health systems lose the top-of-the-funnel to these new entrants, they will lose control of the patient relationship and will depend on these massive organizations to feed higher-acuity volumes and to survive. Who will win the funnel wars?Will the Amazons and Apples of the world win The Funnel Wars? Or perhaps a health system or multiple health systems? The answer has yet to be determined, but with the top five Fortune 500 companies (1. Walmart 2. Amazon 3. Apple 4. CVS Health 5. UnitedHealth Group) investing billions into their health offerings, it will be a tight race.The Funnel Wars will end in a place where we have a large, nationwide offering that integrates the full consumer experience. As more entrants join healthcare's gold rush, this integration will become more challenging.Many health systems still think this is an esoteric threat because no one player has completely figured it out. CVS seems to be the biggest threat to health systems due to proximity to consumers, close relationship with Labcorp, and intention to convert locations to “Health Hubs”.It's easy to look at stumbling efforts to "figure out" healthcare (I.e., Haven, Walmart Health) and think that the disruptors are failing. The problem with this thinking is that it discounts the learnings these giants glean from their efforts that they will apply to future attempts.In order to disrupt an existing model, you need to improve access, convenience, and cost. Health systems are committed to quality – often to the detriment of cost – while innovators come in at lower cost and build up to higher quality.  

Us when talking about healthcare in the US and singing our favorite Avril Lavigne throwback: “Why'd you have to go and make things so complicated?” But, seriously, healthcare in the US is no walk in the park. In fact, it's more of a walk in a corn maze -- disorienting, confusing, and altogether spooky. To break down some of the basics, we had the honor of hosting Julie Oliver, Executive Director and Co-Founder of Ground Game Texas on this episode. Giving us the 411 on healthcare finance, citing a career in the industry and political know-how, Julie pulled back the red tape on medicare, medicaid, and everything else under the sun that has us scratching our heads. LIMITED EDITION MERCH (only avail. through Nov. 16): https://www.bonfire.com/store/girlandthegov/ Citizen Power with Nathalia Ramos & Ben Sheehanhttps://www.onecommune.com/a/2147492814/nBoX9mJoPrima:https://www.prima.co/ Use code GIRLGOV for 20% offhttp://chng.it/8CNwdhLT79 Prima PetitionBrand Ambassador Sign Up Form: https://docs.google.com/forms/d/e/1FAIpQLSelH0p5KWISaHaBI5-9nKSUItlY_eXiEmvsudpJIcRjKhfgyA/viewformBrand Ambassador Info Sheet:https://drive.google.com/file/d/11WAWLwc9dShbSVxPMcUzc1d5Ua8KNdO2/view

Erik Lindenauer is the founder and Executive Chairman of Housing & Healthcare Finance. He is interestingly, the second person we've spoken to on the podcast, who got his start in sales by selling shoes. We'll examine a potential connection between selling shoes and origination, creating a positive customer experience, and how to stay motivated in the origination game.TIMESTAMPS: 2:30 - 7:00 - Early Sales Experiences and Mom's Pottery7:30 - 34:00 - Creating a Positive Customer Experience35:00 - 39:00 - Choosing Your Client39:00 - 42:30 - Retail Sales vs Origination Sales42:30 - 51:00 - Staying Motivated51:30 - 59:00 - Finding Your Team and Working Together

The team of brothers Luke and Tyler Johnson join Bill Neumann on the Group Dentistry Now Show. Luke Johnson, Chief Marketing & Experience Officer and Tyler Johnson, CEO discuss Healthcare Finance Direct's deep experience in the DSO industry. Contact Luke Johnson @ lukej@healthcarefinancedirect.com to find out how they can help your DSO or emerging dental group. Healthcare Finance Direct is a technology platform that allows healthcare providers to offer innovative pay-over-time options to every patient, regardless of their credit. Protect your balance sheet while optimizing for revenue growth. Though conventional bank-backed options help, they only solve about half the problem. So healthcare providers are left with a large subset of their customers that don't have a way to pay. When patients don't have the cash or great credit, everyone loses. Healthcare Finance Direct offers alternatives that take everyone into account. If you like our podcast, please give us a ⭐⭐⭐⭐⭐ review on iTunes http://apple.co/2Nejsfa Our podcast series brings you dental support and emerging dental group practice analysis, conversation, trends, news and events. Listen to leaders in the DSO and emerging dental group space talk about their challenges, successes, and the future of group dentistry. The Group Dentistry Now Show: The Voice of the DSO Industry has listeners across North & South America, Australia, Europe, and Asia. If you like our show, tell a friend or a colleague.

The 3rd Season is Officially Here! Join Oregon HFMA's current president, Tammie Coon, and hosts Kelly Smith and Jeff Johnson as they interview Healthcare Finance executives about the impact of the Vaccine Mandate on healthcare system in Oregon and the United States. In this podcast, they share best practices in dealing with all of the challenges and advice for the future. It's another AMAZING episode

Don't miss out on the next WeAreLATech podcast episode, get notified by signing up here http://wearelatech.com/podcastWelcome to WeAreLATech's Los Angeles Tech Community Spotlight!   “Haley Hamer of Healthcare Finance Direct”WeAreLATech Podcast is a WeAreTech.fm production.To support our podcast go to http://wearelatech.com/believe To be featured on the podcast go to http://wearelatech.com/feature-your-la-startup/Want to be featured in the WeAreLATech Community? Create your profile here http://wearelatech.com/communityHost,Espree Devorahttps://twitter.com/espreedevorahttps://www.linkedin.com/in/espreeGuest,Haley Hamercontact.totallytech@gmail.comhttps://www.linkedin.com/in/haley-hamer/Listener Spotlight,Brian Swichkowhttps://www.linkedin.com/in/swichkow/For a calendar of all LA Startup events go to, http://WeAreLATech.comTo further immerse yourself into the LA Tech community go to http://wearelatech.com/vipLinks Mentioned:Haley's Instagram, https://www.instagram.com/totallytech.io/Healthcare Finance Direct, https://www.healthcarefinancedirect.comMatLab, https://www.mathworks.com/products/matlab.htmlMedium, https://medium.comProduct School, https://productschool.comMirro, https://mirro.ioBitwise Industries, https://bitwiseindustries.comMesh Cowork, https://www.meshcowork.com/enCredits:Produced and Hosted by Espree Devora, http://espreedevora.comStory Produced, Edited and Mastered by Cory Jennings, https://www.coryjennings.com/Production and Voiceover by Adam Carroll, http://www.ariacreative.ca/Team support by Janice GeronimoMusic by Jay Huffman, https://soundcloud.com/jayhuffmanShort Title: Haley Hamer

Today's guest is Manny Akintayo, Co-Founder and Chief Technology Officer at Gentem Health in San Francisco. Founded in 2019, Gentem Health is a Silicon Valley-based company with a simple mission: Get healthcare providers reimbursed more and faster with minimal administrative cost. Gentem accomplishes this by leveraging technology such as Artificial Intelligence, Automation & Data to streamline and accelerate the reimbursement process. In today's episode, Manny tells us about: Their mission at Gentem Health, Problems they are solving within Healthcare Finance, Challenges the team needs to overcome, What he has learned in his journey at Gentem, The impact of the Covid-19 within their business, Success stories of the benefits they bring to clients, What the future holds and plans for growth, and What he looks for when hiring into the team

Don't miss out on the next #womenintech podcast episode, get notified by signing up here http://womenintechshow.com. Be featured in the Women in Tech Community by creating your profile here http://womenintechvip.com/“Haley Hamer of Healthcare Finance Direct”#womenintech Show is a WeAreTech.fm production.To support the Women in Tech podcast go to https://www.patreon.com/womenintechTo be featured on the podcast go to http://womenintechshow.com/featureHost, Espree Devorahttps://twitter.com/espreedevorahttps://www.linkedin.com/in/espreeGuest,Haley Hamercontact.totallytech@gmail.comhttps://www.linkedin.com/in/haley-hamer/Be featured in the Women in Tech Community by creating your profile here http://womenintechvip.com/Listener Spotlight,Ulviyya Jafarlihttps://www.linkedin.com/in/ulviyya-jafarli-924453156/In LA? Here's some awesome resources for you to become immersed in the LA Tech scene -For a calendar of all LA Startup events go to, http://WeAreLATech.comGet Podcast Listeners, http://getpodcastlisteners.com/Resources Mentioned:Haley's Instagram, https://www.instagram.com/totallytech.io/Healthcare Finance Direct, https://www.healthcarefinancedirect.comDumb Blonde Data, https://www.dumbblondedata.comMatLab, https://www.mathworks.com/products/matlab.htmlMedium, https://medium.comProduct School, https://productschool.comMirro, https://mirro.ioCreator Now, https://creatornow.clubCredits:Produced and Hosted by Espree Devora, http://espreedevora.comStory Produced, Edited and Mastered by Cory Jennings, https://www.coryjennings.com/Production and Voiceover by Adam Carroll, http://www.ariacreative.ca/Team support by Janice GeronimoMusic by Jay Huffman, https://soundcloud.com/jayhuffmanShort Title: Haley Hamer

Another amazing podcast with Oregon HFMA's current president, Tammie Coon, as she and hosts Kelly Smith and Jeff Johnson cover an important national bill being voted on by the Senate that could change the face of healthcare collections. Key Bank, an Oregon HFMA Diamond Sponsor, joins the podcast to share the secrets to Healthcare Finance in 2021. It is a CFO must listen and watch podcast. President Tammie Coon also announces the next in-person Oregon HFMA event. This is a fantastic podcast you will not want to miss!

Fred is one of the top health care originators in the country. In this conversation, Mordecai interviews Fred about his relentless pursuit for a sales position at American Express, how he applied unsuccessfully six years in a row for a sales role, and then went on to become the top sales team member. Timestamps:1:20 – 10:15: First Sales Experience and the Importance of Relationships 10:15 – 15:55: Challenges with Connecting with People during COVID, Zoom Calls, and Developing the Customer Relationship15:55 – 24:18: Human Connection, First Impressions and Breaking Down Barriers24:18 – 34:58: Entrepreneurial Culture, Problem Solving, Identifying What A Customer Needs and Adding Value34:58 – 47:07 Being a Hero to Your Customer, Holding Yourself to a Higher Standard to Succeed47:07 – 51:51: What Makes A Good Client?51:51 – 59:39: Pushing Through Challenging Times and Building Confidence

Today's guest is David Keyes, who is the Director of Administration and Finance at Brigham Health. In his role at Brigham Health, he serves as a senior advisor to the President of Brigham and Women's Faulkner Hospital, SVP of Surgical and Procedural Services, and the Chief Financial Officer of Brigham Health regarding strategic and operational initiatives. Prior to joining Brigham Health as a Deland Fellow in Health Care and Society, Keyes was the Senior Manager for Strategy and Analytics at the American Academy of Physician Assistants in Washington, DC. He earned his Master's in Healthcare Management from Johns Hopkins University and his Bachelor's from SUNY Geneseo. In this episode, Yolanda and David discuss what a career in healthcare finance and administration entails, challenges he faces in his role, resources to help keep you up-to-date with the latest healthcare news, advice on administrative fellowships and first career roles, and so much more!  Connect with David on LinkedIn at: https://www.linkedin.com/in/david-keyes-79a90961/ Check out more details about the Deland Administrative Fellowship at: https://www.brighamandwomens.org/about-bwh/deland-fellowship/description Learn more about Brigham Health here: https://www.brighamandwomens.org/about-brigham-and-womens-hospital    

Jonathan Burroughs is President and CEO of The Burroughs Healthcare Consulting Network, Inc. He works with some of the nation’s top healthcare consulting organizations to provide ‘best practice’ solutions and training to healthcare organizations throughout the country.Dr. Burroughs serves on the national faculty of the American College of Healthcare Executives and the American Association for Physician Leadership, where he has been consistently rated as one of their top speakers and educators.He is the author or coauthor of many books on healthcare leadership including, Redesign the Medical Staff Model - A Collaborative Approach, which was the winner of the 2016 James A. Hamilton Award for Outstanding Healthcare Management Book of the year.Dr. Burroughs received his bachelor’s degree at Johns Hopkins University, his MD from Case Western Reserve University, and a healthcare MBA with honors from the Isenberg School of Management.We hope you enjoy our conversation where we talked about knowing yourself, the importance of physician healthcare executives, and following the money in medicine. As always, if you like what we’re doing give us a positive rating and follow our social media pages for more content. We hope you enjoy this episode of Leading The Rounds. Questions we asked included: How did you develop your leadership philosophy? Tell us about Burroughs consulting? How do we follow the money in medicine? How do trainees learn the business of medicine? Our favorite quotes: “Learn from every single patient. That’s why they call it the practice of medicine” “Look in the mirror and see who you are… then exploit the strengths and minimize the weaknesses.”“If you don’t learn the business, you are going to be delegated to the assembly line.” “Doctors who only know how to diagnose and treat patients will be treated as a commodity in the coming century.” “He or she who controls the money, controls the system.” Book Suggestions: French’s Differential Diagnosis Introduction to Healthcare Finance by Carlene Harrison and William P. HarrisonEssential Operational Components for High Performing Healthcare Enterprises by Don Burroughs  The Innovator's Prescription by Clayton Christensen and Jason Hwang 

Thank you for tuning in to this week's episode of the Caffeinated Brown Girl Podcast. On this podcast we talk to and about South Asian pioneers, business owners and trailblazers making a difference in the world. This week's episode, which is also the final episode of season 2, features Nikita Chatterjee, the Co-Founder and Chief Executive Officer of PAANI, LLC. She recently graduated with her Bachelor's degree from Syracuse University, and is now pursuing a career in Healthcare Finance. Growing up, her parents always emphasized the importance of giving back and building community, which is where her passion for healthcare stemmed from. She loves the idea of impacting lives in any way possible and wanted to find a way to bridge her love for health and healthcare with the excitement of business development. That's how PAANI was born - the need to fill the gap and find a solution for underserved communities using innovative strategies. She is excited to be at the forefront of the intersection between social impact, advanced technology, and cultural preservation. Leave a review on Apple Podcasts: https://podcasts.apple.com/us/podcast/the-caffeinated-brown-girl-podcast/id1492181471?ign-mpt=uo%3D4 Connect with the Podcast Instagram: https://www.instagram.com/caffeinatedbrowngirl/ Email: caffeinatedbrowngirl@gmail.com Connect with PAANI Instagram: https://www.instagram.com/paanisolutions/ Website: www.paanisolutions.com

Andrew Lo discusses his various fields of expertise and research with Anastasia Diakaki. Professor Lo's most recent work in healthcare finance, more timely than ever, serves as the starting point for a conversation covering the COVID-19 pandemic, machine learning applications in biopharma, artificial intelligence and the interpretability of machine learning results in the finance industry. When it comes to preparing for the future, we ask Andrew Lo: "Do we all need to become computer scientists?"   Topics discussed: 1:30 - Professor Lo’s philosophy and approach in health care finance sector 2:43 - Applications: what are the implications of these tools? 4:51 - Lo’s view on the pandemic and the acceleration of some processes 6:41 - Machine learning applications and health care 8:58 - Successes and improvements to algorithms in practice 10:57 - Computer science – the new life skill to have 13:24 - Machine learning algorithm used in the investment process 15:25 - Are your current students more comfortable with science skills? 16:55 - AI and human intelligence   Related articles and links:   CFA Institute members and charterholders Professional Learning Tracker https://cpd.cfainstitute.org/ ____   ► Subscribe to the Take 15 channel here https://www.youtube.com/channel/UCA3HUMuK4FSp_CvQH_2Ji7g   ►Email us for comments, questions, or appearance requests:Take15podcast@cfainstitute.org   ____   Find Andrew here:   LinkedIn: https://www.linkedin.com/in/andrewwlo/   Twitter: https://twitter.com/AndrewWLo?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor   Find Anastasia here:   LinkedIn: https://www.linkedin.com/in/anastasiadiakaki/?originalSubdomain=uk   Twitter: https://twitter.com/anastdiakaki -- Find Lauren here:   LinkedIn: https://www.linkedin.com/in/lauren-foster/   Twitter: https://twitter.com/laurenfosternyc -- Listen to us on:   Libsyn: http://take15audio.cfainstitute.libsynpro.com/   Spotify: https://open.spotify.com/show/4z0UYTI6B1pfSk5UrpCqFk?si=VzxBsKUWTme_D9PSk25r3g   Apple Podcast: https://podcasts.apple.com/us/podcast/take-15-podcast/id268942353

We recorded this episode at our February 2021 Data Science Salon Virtual on Healthcare, Finance & Technology. Formulated.by’s Senior Content Advisor, Q McCallum, sat down with Ayda Farhadi, Senior Data Scientist at UPS, and Vasileios Stathias, Lead Data Scientist at Sylvester Comprehensive Cancer Center to discuss applying AI to healthcare.

Healthcare Finance Direct, LLC is a team of amazing people who seek to provide the absolute best experience to both patients and providers. They like to think of themselves as a "finance as a service” because they offer a unique solution to patient financing, centered in financial clarity for patients. They work with both large corporations that have custom workflows and small practices, but the goal is always the same: treat more patients. Get in touch with Healthcare Finance Direct Here: Website, Facebook, and LinkedIn Get social with us here: Webpage, Facebook, Instagram, Contact Us

  Don't forget to share, subscribe, comment and leave us a rating! This episode with Annalisa Abell was powerful! Annalisa has a bachelor's degree from The University of Kentucky and a masters degree from Morehead State. She currently works in Healthcare Finance. In addition to investing in real estate, she is a personal finance coach and recently launched a course showing others how to become debt free. She personally was able to pay off her student loan, car and credit card debt in one year.   Her interest in real estate started in college after realizing how much rent her landlord was bringing in. She immediately thought that she could do the same thing. Last year, she purchased a duplex that she househacks. In this episode we discuss the Cincinnati market, house hacking, being debt free, future plans and more.     Pre-Order my new course! A Beginner's Guide to Buying Your First Out of State Property- https://gum.co/LLMiR Connect with us! Join our email list- http://bit.ly/bredlist Buy your Black Real Estate Dialogue Tee- http://bit.ly/bredtee    Buy my Ebook & Webinar Bundle- "How to Start a Successful Podcast on a Budget with NO EXPERIENCE!"- https://gum.co/bTrYh From our Partners! Real Estate Courses & EBooks  Deandra McDonald House Hacking Course- bit.ly/DMhousehack Deandra McDonald Landlord Life Course- bit.ly/Dlandlord The Rental Toolkit: Investing Resources- https://bit.ly/RentalBundle Fire your Landlord and Live for Free!- https://bit.ly/infamoushousehack Real Estate Deal Analyzer Bundle- https://bit.ly/pettwaybundle Side Hustle Courses & Ebooks Todd Capital Courses- http://bit.ly/toddcourse Todd Capital Vending Machine Course- https://bit.ly/toddvending Todd Capital Options Trading Course- https://bit.ly/tcoptions2 Ultimate DIY Credit Repair Guide- http://bit.ly/ultimatecred Mobile Notary Public Course (Use Code "BRED" for $300 off)- https://bit.ly/ahnotary Learn How to Become a Great Affiliate- https://bit.ly/IGmonetization Learn How to Monetize Your Instagram- https://bit.ly/monetizeIG2 Make Passive Income with Car Rentals- https://bit.ly/infamouscarrental Learn how to Build a 6 Figure Side Hustle- https://bit.ly/6figsidehustler Learn how to Save like the Wealthy- https://bit.ly/wealthhysaver Learn How to Flip Phones- https://bit.ly/phoneflipper1  

Happy Labor Day weekend, listeners! Cross Currents is back this week to talk about the pandemic as we begin month six of our heavily-disrupted new day-to-day normal. Joining us today are Dr. Barry Chaiken, a Harvard-trained doctor who is board certified in Public Health and one of the nation's leading experts applying public health technology during crises; and Sheila Bair, NYT bestselling author, former college president and FDIC chair who played a critical role in the federal response to the '08 financial crisis. Tune in now and make sure you're following @nprcrosscurrents to stay up-to-date with the show!

Michael Allen has unique expertise in healthcare finance. He’s been chief financial officer at four different health systems and is national chairman of the Healthcare Financial Management Association (HFMA) where he regularly interacts and shares knowledge with peers in the 56,000-member organization.Michael calls HFMA his side hustle and is going on his second year of a one-year term since the organization froze its leadership to provide stability during the COVID-19 pandemic. His primary role is CFO at OSF Healthcare, a faith-based health system in Peoria, Illinois with 23,600 Mission Partners in 147 locations, including 14 hospitals.Since the pandemic started, the Healthcare is Hard podcast has explored how health systems are dealing with it from multiple angles including from the CEO, CIO, regulatory, governance and supply chain perspective. In this episode, Keith Figlioli talks to Michael Allen to learn how finance leaders are supporting the healthcare industry and their organizations through this trying time.Michael talks about how healthcare has historically not been very agile because realities like fixed costs, reliance on bricks and mortar and steady organic growth meant that it didn’t have to be. But he talks about the new need for agility, how OSF is adapting, and how some steps the organization took before the pandemic put it in a better position to respond. The topics Michael and Keith discuss include:Supporting quick decisions. Through its emergency operations center created to navigate the pandemic, Michael says OSF learned how slow the organization had previously been at making decisions. This wasn’t an issue before because it worked, but COVID forced a need for change. Instead of including everyone in every decision, Michael talks about how OSF learned to rely on small groups to make decisions, vet those decisions with the larger group, and then move forward quickly.Spending less time in the rear view. Michael is working to flip the traditional model of healthcare finance. Instead of looking backwards and planning based on previous experiences, Michael is directing his team to spend most of their time looking forward. For example, no one in healthcare knows what their future revenue stream will look like as the payer mix shifts and the average payment rate for services is likely to decline. This is why it’s critical for finance teams to spend more time forecasting and ensuring they’re nimble enough to respond to any situation.Eliminating the annual budget process. OSF entered its fiscal year starting October 2019 without a traditional budget. Michael and his team still updated their long-term financial plan and set financial targets on an annual basis, but spent less time on individual line items. Instead, they focused more on forecasting and dynamic planning, including measurement and processes for reacting to issues. This proved to be invaluable when the pandemic hit and as the healthcare industry faced rapid change, enabled OSF to quickly gather the information it needed, build forecasts, and move quickly.Creating an environment where innovation is inherent. Another area that bolstered OSF’s response to the pandemic is its focus on innovation – something Michael says has always been an integrated part of the organization versus a separate entity. In OSF’s venture arm for example, investments are never solely made for their financial benefits, but must also be doing something positive for the organization and be endorsed by clinical leaders. As the response to COVID-19 placed digital touchpoints first, this gave OSF a running head start in how it adapted.Hear Michael and Keith dig into these topics and more in this episode of Healthcare is Hard: A Podcast for Insiders.

Shelley Samuels joins Kristin to talk about how the field of Behavioral Health has changed and the impact this had made on consulting services. Shelley Samuels has 30+ years of experience as a leader in human services and healthcare organizations. Most recently she was COO and Compliance Officer for national organization Juvo Autism and Behavioral Health. Prior to that she was the Chief Program Officer of Easterseals New Jersey while concurrently serving as the COO of Easterseals Solutions an EHR system administration entity for multiple nonprofit organizations. She has an MPA in Public Administration with a concentration in Healthcare Finance from Rutgers University. She completed an Executive Leadership Program at Columbia University’s Graduate School of Business and a program at New York University Stern School for Executive Education in Finance and Accounting. Ms. Samuels has secured and managed more than $80 million dollars in grants and contracts such as Projects of National Significance from the US HHS; US Administration on Aging; US Corporation for National and Community Service; SAMHSA; HUD and a federal healthcare insurance education project. Ms. Samuels has served as a management and development consultant for organizations such as federally qualified health centers; medical centers; hospice and health and human services. She has provided consulting on medical legal partnerships and older adult services. Shelley has expertise in fee for service and transition to multiple payment models. Ms. Samuels has made presentations on EHR best practices at multiple conferences and webinars as well as on disability rights, behavioral health homes and access to employment for local and national audiences.srsstrategic.com

The cost of healthcare is a mystery for two reasons. First, the average consumer does not understand the essential costs of providing care such as clinical cost, facility costs, and ancillary support costs. Second, the methods for pricing, billing, and collecting payments is extraordinarily complex. Understanding both the total cost of care and the reimbursement for that care is important for an HTM professional as these factors can drive each other. In other words, the more it costs to treat patients (including equipment service operations) the more we must charge for the care. And conversely, the less the insurance companies are willing to pay, the more expense we need to cut out of our costs. It’s a push and pull relationship.

Epic Founder and CEO Judy Faulkner made headlines last week with an email urging clients to join Epic in opposing a proposed rule from the Dept. of Health and Human Services (HHS) around information sharing. Citing privacy concerns on behalf of patients, Faulkner said she hopes to collaborate with HHS but also said Epic may sue if the final rule does not adequately address the company's concerns. This special episode of Voices in Healthcare Finance includes HFMA's Rich Daly and Chad Mulvany discussing Faulkner's recent comments as well as HFMA President and CEO Joe Fifer's interview with Faulkner, originally released in 2019. In that interview, Faulkner talked about her leadership philosophy and what it takes to launch an enterprise like Epic from the ground up.

The "M" Word - "Money" - something that is not often discussed in the clinical encounter. Let's learn about different ways of paying for healthcare, find out some fascinating statistics, and learn how to better be informed on options for how to contain your costs when you get care. Learn about medical cost-sharing communities, and other insightful tips on how to empower yourself to get high quality care at affordable costs.

This is a unique Podcast about Healthcare Finance challenges and solutions in the State of Oregon and the Western United States with the current president of the Oregon Healthcare Financial Management Association.If you are interested in finance and healthcare or work with a hospital or medical facility, you don't want to miss this podcast.

From the team that brings you Voices in Healthcare Finance comes Cup of Joe, a new podcast featuring conversations between HFMA's President and CEO, Joe Fifer, and key industry thought leaders.  In today’s preview episode, Joe talks with Gail Wilensky, PhD, an economist and senior fellow at Project HOPE who served as a senior adviser to President George H.W. Bush.  Watch the podcast feed at hfma.org to listen to the debut season this summer.

In this episode of The Women's Pelvic Pain Podcast we are joined by a pelvic pain patient herself, Li Boynton, who not only discusses how botox tremendously helped her pelvic pain symptoms, but also how to navigate the complex process of getting botox covered by your insurance along with different programs that can help patients to cover the cost of botox. Li majored in biomedical engineering at Yale and works in Healthcare Finance at JP Morgan asset management, covering therapeutic stocks, such as pharma and biotech, including allergen who manufactures and produces botox. Throughout her career, she has developed a close relationship with the head of R&D at Allergan and shares with us what she has learned through conversations with him, in regards to the use of botox for pelvic pain and the future plans that Allergan has to get botox FDA approved for pelvic pain specifically. The two programs that Allergan has to help lower patients out of pocket costs are: 1. The Botox Savings Program - can be used by anyone regardless of age, income status, insurance, etc. The claim has to be approved by your insurance. This program is funded by Allergan. https://www.botoxsavingsprogram.com/ 2. Botox Patient Assistance Program - This is for uninsured and low income individuals who want to use the treatment of botox but can't afford the out of pocket costs. You have to make under a certain income bracket to be approved and this is also funded by Allergan. https://www.botoxone.com/PatientAssistanceProgram ________ Li's E-mail: Lisboynton@gmail.com Dr. Tayyaba Ahmed, DO - Pelvic Rehabilitation Medicine https://www.pelvicrehabilitation.com/about/tayyaba-ahmed-do/ _____________ LISTENER DISCOUNT Leslie Howard's Pelvic Liberation Book: lesliehowardyoga.com/product/pelvic…beration-book/ Discount code: pelvicflooryoga10

This Podcast is a continuation of the previous Podcast on the announcement of Aspen Dental opening locations in 2 Walgreens located in Florida. Please turn-in to that episode for those details. Briefly, in that episode, I reviewed data provided by the ADA which illustrated the changes occurring in dentistry, both in regard to 1) utilization, and 2) practice ownership. I also shared some distinct differences between dentistry and medicine, as it is proposed that as Medicine goes so goes Dentistry. Medicine is 5 times the size of dentistry, both in the number of providers as well as total expenditures. To equate them is an oversimplification of market forces. My takeaway points from that episode were the following: 1. The Utilization of dental care is changing. 2. The delivery setting of care is also changing as is the payment method. 3. Seniors are going to become an important driver of the dental care economy. 4. Cost, no teeth, fear, inconvenient location or time, trouble finding a dentist, as well as no perceived need are the greatest barriers. 5. Corporate dentistry as identified under-severed market segments and has created offerings to meet these needs. 6. 63% of adults do not see a dentist, that is a huge market of potential patients. 7. Your job is to make the “non-dental patient” into a patient in your practice. If we can do that there is plenty of care we call can deliver. 8. You can start by addressing the barriers in point #5; cost, fear, convenience, time, no teeth, no perceived value. 9. There is no canned, boiler-plate solution, each practice is different, with different markets and challenges. Finally, I disagreed with the following statement by the ADA: ... a lot more finance, data, marketing, and managerial expertise is going to be needed to run a successful dental practice. Will dental schools attempt to cram a mini–MBA into an already stretched dental school curriculum? Will dentists increasingly pursue training to improve managerial and organizational leadership skills? Or will we increasingly see the separation of clinical and management functions, with fewer dentists engaged in the business side, leaving that to people with MBA degrees? The ADA is convinced it will be primarily the latter. I will use this podcast episode to expand on this. A few years ago I was told by a friend and faculty member of a dental school, that his students didn't need to know anything about business because they are all going into corporate dentistry. This perspective was repeated again recently at a local dental society meeting I attended. Students should not feel they are ill-prepared to enter professional practice before they even start practice, or that their choices are limited. This, my friends, colleagues and listeners, we can not allow this to happen. Let's not make this into a self-fulling prophecy by ignoring the need for basic business skills in dental practice. Basic Business skills, well taught, will enable a greater standard of care to be delivered to each and every patient we serve. I am a dentist and oral surgeon who went back to school after nearly 25 years in practice to complete my MBA, so I can speak to this with some degree of expertise. Dentists are well capable of learning basic managerial and organizational skills needed to run their practices, an MBA is not required! It is dangerous for any organization to be overly influenced by a group think mentality. Effective organizations have a Devil's Advocate to guard against such. The Devil’s Advocate task is to bring forth alternative ideas even if they are unpopular, unliked, or in opposition to the powers that be. It is important that they are heard and considered. Dentists completely relinquishing all ownership and business functions to a Management Organization, ie, DSO is a rather extreme solution, especially when solutions exist that others practitioners have figured out. That’s why there are Business Coaches, Consultants, and Advisers as well as resources at the ADA to help educate practitioners about business practices. A Net Present Value Analysis reveals that over a 30-year dental career the difference in earnings between an owner dentist vs an employee dentist can be several million dollars. Do not freely and readily give up your greatest asset, your license! DSO's along with other Corporate Entities have done their financial analysis homework and know this, that is why they are capable of offering young dentists lucrative financial arrangements. They do this because they can! They know dentistry can be highly profitable so they can offer exceptional financial incentives. Remember, they haven't spent 8 years or longer in school to acquire the education and skills needed to gain a dental license, but you did!! Be aware of how financially valuable your license is, and never forget it! It is the greatest financial asset you have! It is also the greatest barrier to market entry! Without a license one is incapable of diagnosing, treating and then billing for services. An executive can not bill even one cent of revenue, yet can end up with even more financial incentives than the dentist working chair-side in the clinic. This just doesn’t seem right…just saying! A recent article in Healthcare Finance reports that the salaries of hospital executives nearly doubled, while physicians saw more modest increases. Between 2005 and 2015, average CEO compensation jumped from $1.6 million to $3.1 Million, an increase of 93 percent. Healthcare professionals saw 10 to 20% increases on average. Is this a good trend?? You be the judge and draw your own conclusion. I only hope this doesn’t for-tell similar disparities for dentists and dental practices as well. Comparing ourselves to medicine, the very best hospitals have Physicians as their CEO's, not Business Executives. Two of the nations best hospital systems, The Mayo Clinic, and The Cleveland Clinic have highly skilled Physician CEO's. And in fact, have been physician lead since their inception over a century ago! I believe there is a lesson there for all of us. Those that know best for the patient should be in charge. I love the quote by Dr. Toby Cosgrove, the past Cleveland Clinic CEO, who wisely and accurately states: "... it's easier to teach a doctor about business than it is to teach an MBA about medicine…” He couldn’t be more right!! An effective CEO or Practice owner does not need to know all the answers, nor should he!! The critical skill for an effective CEO is to be observant, ask the difficult questions and surround himself with a highly knowledgeable C-Suite of executives or consultants who can find those answers. Dentist leaders are uniquely qualified to bridge the gap between business and clinical practice. Because only they can see both sides, they can help their practices and organizations take outstanding care of their patients, while deploying resources and assets wisely. Remember our Tag Line to this podcast...... "It's not what you don't know that will hurt you, it's what you know for sure that just ain't so that will!” attributed to Will Rogers I am also reminded of the old saying, “he who pays the piper picks the tune!” He who controls the assets has the final say, always! You should be aware that there are other organization structures in addition to DSO's that enable one to maintain ownership and control while providing an experienced business team. The solo practitioner can create strategic alliances with a highly trusted team of coaches, consultants and advisers to provide the critical business knowledge necessary to guide your practice. Beyond the solo practice is a group practice. As the number of providers and locations increase a dedicated and professional administrative team can be better supported as well as afforded. Growing one's practice through a merger or acquisition of smaller, solo practices is a great tactic. These practices typically are owned by senior practitioners who have, over time, allowed their practices to contract by working fewer and fewer days. Acquiring these practices is a great win-win for both sides as the acquiring practice achieves growth at a very reasonable cost, and the selling practice has achieved a transition plan. Another alternative to DSO's is IPA's, no not the beer! IPA is an Independent Practice Association. In this structure, each practice in the Association remains independent. Practitioners join together within a legal structure that creates a management layer above all the practices. This management team, who represents a sizable number of practices, can better negotiate vendor contracts, insurance contracts, HR management, IT support as well as numerous other business functions. This entity may become more common in the future. Finally, one can seek out numerous educational opportunities to become more business savvy. Online classes, seminars, and books are just a few. The ADA has lots of practice management resources as well as webinars to provide excellent business and practice management education. The ADA Kellogg Executive Management Program in addition to the ADA Executive Program in Dental Practice Management is two more comprehensive programs offered to members. Please be sure to check them out. Consider the American Association for Physician Leadership too! It is how I began my formal business and leadership training. Dentists are welcome! The online courses are exceptional and highly relevant to practice. So to summarize our Take Home Points to Ponder are: 1. The delivery of dental care is changing. 2. Corporate along with Retail settings will continue to evolve. 3. The news of the demise of private practice, I believe is premature. 4. A dental license is your most valuable financial asset, it is extremely hard to obtain, only about 195,000 exist in the US. 5. Dentists know what is best for their patient, as such should be the ones in charge. 6. Dentists are well capable of managing their practices. 7. Consultants, Group practices as well as IPA's can help offload complex management functions. 8. Business knowledge, at a basic level, is readily attainable by everyone. Finally, If you are unsure how to accomplish any of these tasks, or don't know where to find such a team please reach out to us here at OmniStar Financial for guidance, we are experts in this! So that wraps things up for this Podcast. We hope that this information has created an “Ah Ha” moment, or stimulated some additional questions you can direct to your advisers. We welcome your inquiry here too at OmniStar Financial. Our contact information can be found on our website OmniStarfinancial.com . You will also find a link to sign up for our newsletter. Please share this podcast if you found it helpful, and leave a review on iTunes too. We welcome your feedback and suggestions for future podcast sessions. Thank you so very much for tuning in and listening. We are very grateful for your time and attention. references: https://doi.org/10.1016/j.adaj.2017.06.017 Practice Ownership is Declining, Sept 2017 JADA. https://success.ada.org/en/practice-management/dental-practice-success/spring-2014/shifts-in-utilization https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/downloads/highlights.pdf https://www.aegisdentalnetwork.com/news/2018/12/17/new-aspe-dental-office-opens-in-collaboration-with-walgreens https://www.ada.org/en/science-research/health-policy-institute/publications/infographics https://www.physicianleaders.org/ https://www.ada.org/en/publications/ada-news/2015-archive/may/2015-ada-kellogg-executive-management-program-registration-opens https://pmcertificate.success.ada.org/ https://www.healthcarefinancenews.com/news/salaries-hospital-executives-nearly-doubled-while-physicians-see-more-modest-increases?mkt_tok=eyJpIjoiTlRrNE1HTmxZbUkyWlRBMiIsInQiOiI2V3RPcE1FK1hDc2hSVkdBNkgyVVp1MkJHUHMwVkU0ZDlzRlcybGFyQWNWbEtSblhHZEttQUxvaXFaRXgyazZwTXRkTkd6YndscXlqUGhnU1R2TXorWnlkQnFlSVM2dnBDd1lvemdRVzVxcFprbWc1TFwvV25TamZXaE84S0o4UkQifQ==

Jed Constantz, DBA As a Healthcare Finance and Delivery Strategic Consultant, Dr. Constantz ensures existing and prospective clients receive maximum value from current and future strategies and initiatives. In previous roles, Jed advised employers on measures to develop regional and community-based physician accountability and commitment through means of enhanced benefits and reduced costs; with the significant benefit of creating sustained loyalty between providers, patients and payers. He has successfully offered strategies that built on four pillars: actionable data, physician alignment, high-risk member targeting and network re-engineering. Having begun his career on the payor’s side of healthcare (Blue Cross/Blue Shield of Central New York), Dr. Constantz has served in several positions for hospitals, home health agencies, physician organizations and physician/hospital organizations. Over his 30 plus years in healthcare, Jed has developed tools and resources for primary care providers and employers seeking to reduce costs, drive greater efficiency and quality outcomes and thereby create a “featured-and-favored” network in their regions and community. This process includes a deep focus on the selection of the right community of primary care physicians and specialists, a thorough audit of existing patient and population data, commitment to accountable care standards and improved compensation for the physician. The end-objective is a better healthcare delivery model with an alignment of “enlightened self-interests” and a balance between rewards and value for the employer, employee and provider. For the employer, the financial benefits are immediate with on-going healthcare savings, a healthy workforce, and improved physician relationships. The provider can see greater patient volumes, improved care standards and compensation tied to performance. The employee will feel an improvement in care and attention, benefit with reduced out-of-pocket expenses and sense a higher level of satisfaction. 01:41 PCMHs - Patient-Centered Medical Homes. 02:30 “What continues to be an issue today is the way primary care gets paid.” 04:14 “...the practice gets paid nothing unless a physician is face-to-face with a patient… and often, that’s not the team member that needs to be face-to-face with the patient.” 08:00 “Services can be more efficient if cash flow is taken into consideration.” 10:42 The National Alliance’s guidance to buy - the payment model being recommended. 13:02 Looking at the claims data and preventing downstream spend. 14:54 “When your care delivery is better aligned with the needs of the covered individual, you are genuinely addressing their chronic condition needs…” 15:17 The other reason why payment reform is so important. 16:26 “There is a gap in understanding what true preventive care is.” 16:40 “True preventive care is more a conversation than it is an examination.” 20:02 The Advanced PCP payment models & the nuances behind these models. 21:04 “These deliverables should be guaranteed for the entire population.” 21:20 “The future value of primary care also is an invitation to redefine what you buy from primary care.” 24:35 The long term vs. short term benefits. 26:33 Jed’s advice on how to “deliver the goods.” 27:17 “Where is the physician in this conversation?” 27:32 Staffing model - “Do they have the right care team?” 27:46 Practice level technology. 28:28 “What is the practice’s continuous quality improvement commitment to ongoing staff training and development?” 30:01 How hospitals are challenged by this model. 30:32 “It’s not a matter of how much revenue they generate. It is a matter of how much margin they generate.” 32:40 You can learn more by visiting Jed on his LinkedIn page.

Host Devon Haase Kim speaks with Kansas Hospital Association CEO Tom Bell about how some major US corporations are taking matters into their own hands with healthcare solutions. The Healthcare Finance with Devon Kim Podcast is a weekly program dedicated to discussing issues of healthcare finance with compassion. To listen to more podcasts, visit haaseandlong.com and also follow on SoundCloud. Production by Matty D. Media with a special thanks to the Lawrence Kansas Public Library.

Joey Krug speaks about evaluating investments at Pantera Capital, why healthcare, finance, energy, and government are ripe for disruption, why too much money is bad for entrepreneurs, why location matters for funds but less for projects, how incumbent tech companies deal with blockchain technology and tokens, why blockchains won't transform information, why people don't care about their privacy and how to overcome that, why progress is much faster than we notice, how Augur got support for Trezor wallets, his experience as a Thiel fellow, why the cost of a university degree far outweighs its value, why theory and practice often differ, why UI/UX is the most important thing that should improve in the blockchain space, and why he would love to fast forward to the year 2048. Joey Krug is the co-founder of Augur, a prediction market and one of the first ICO on Ethereum. He is also co-chief investment officer at Pantera Capial's crypto hedge funds. Before joining Pantera, Joey built a point of sale system enabling Bitcoin payments with sound and Bluetooth, and he also started an AngelList syndicate that is now one of the top fifteen by backing. Joey Krug: https://www.linkedin.com/in/joeykrug, https://www.twitter.com/joeykrug AngelList syndicate: https://angel.co/joeykrug Pantera Capital: https://www.panteracapital.com, https://twitter.com/PanteraCapital Augur: https://www.augur.net, https://twitter.com/AugurProject Peter Thiel's book "Zero to One": https://www.goodreads.com/book/show/18050143-zero-to-one Bitcoin white paper: https://bitcoin.org/bitcoin.pdf Ethereum white paper: https://github.com/ethereum/wiki/wiki/White-Paper The Blockchain and Us newsletter To stay up to date about what blockchain pioneers, innovators and entrepreneurs from all around the world think about the future of this space, sign up for the newsletter on http://www.theblockchainandus.com.

Welcome to Voices in Healthcare Finance. If you’ve listened to our podcast before, you’ll no doubt notice some differences in today’s episode. That’s because today, we’re debuting a brand new version of the podcast. From now on, we’ll begin each episode with the latest healthcare business news, then deliver provider stories and practical advice for healthcare finance leaders like you. We’ll release new episodes every other Wednesday with occasional bonus episodes that go in depth about a particular topic. On today’s episode, we begin a series that focuses on best practices in the revenue cycle. Then, we’ll discuss key opportunities to educate patients about their financial obligations.

Martie Ross, Principal at PYA, was one of our first guests on the Future of Health Podcast. Last year, we talked about the earliest days of MACRA and MIPS, among other things. In this conversation, we come back to those issues, and Martie gives us an update on the attitudes within the healthcare industry around these still-new value-based care models. In addition, she talks about what CMS is up to and her outlook on the many new programs the agency is running through Medicare. We also touch on consolidation, telehealth, and consumerization of healthcare.

Voices in Healthcare Finance will debut a new format on September 5. In this sneak peek, Erika Grotto interviews Sandra Wolfskill, one of HFMA's directors of healthcare finance policy, for the first installment of a six-part series about patient communication and the revenue cycle. Sound editing by Julian Suga and Bryan Kuhn.

Transcription Outsourcing, LLC provides transcription services. They work with government agencies, single practice attorneys and physicians, as well as entire university systems to provide fast, accurate, and reliable transcription services. Specialties include medical transcription services (including EHR integration), legal transcription services, law enforcement transcription services, academic transcription services, podcast transcription, and financial transcription services. We provide a user friendly, cost effective, outsourcing option for a wide range of industries.  They also work with the Arkansas State Police, University of Colorado Boulder and Denver, VA New York, Lane County Health and Human Services, Colorado Department of Revenue, and the Colorado Department of Healthcare Finance and Policy. However, I wanted to find out more about Ben's journey and his vast experience in the freelancer economy. We discuss the changes he has seen over the years and how bootstrapping freelancers have evolved from DIY mindset to a DIFM (Do It For Me) movement.    

Scott McDonald, Oliver Wyman’s Chief Executive Officer, discusses consumer trust. Scott shares a few memorable stories from his own experiences working in financial services. Learn what important lessons those in healthcare can learn from banking’s consumer missteps. For more information on our podcast, follow us on Twitter @OWHealthEditor, visit our online healthcare publication at health.oliverwyman.com, and see our full guest roster at https://www.oliverwyman.com/our-expertise/industries/health-life-sciences/oliver-wyman-health-podcasts.html.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit is joined by Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. He has a Masters Degree in Bioethics, Science and Society from CUNY in New York City. Dr. Newton is the author of the book, "Without Your Consent, The Hijacking of American Health Care". They will discuss how the outside influences on healthcare has led to a loss of trust between doctor and patient.

Host: Roy Levit, MD Guest: Michael Newton, MD Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care to hospitals to government that are influencing the way MD's practice medicine today.